Acknowledgement
This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C3076) and a grant of the Dios Pharma R&D 2019 Project.
References
- H.M. Blau, G.Q. Daley, Stem cells in the treatment of disease. N. Engl. J. Med. 380, 1748-1760 (2019)
- S.H. Hwang, S.Y. Kim, S.H. Park, M.Y. Choi, H.W. Kang, Y.J. Seol, J.H. Park, D.W. Cho, O.K. Hong, J.G. Rha, S.W. Kim, Human inferior turbinate: An alternative tissue source of multipotent mesenchymal stromal cells. Otolaryngol. Head Neck Surg. 147, 568-574 (2012)
- S.H. Hwang, S.H. Park, J. Choi, D.C. Lee, J.H. Oh, S.W. Kim, J.B. Kim, Characteristics of mesenchymal stem cells originating from the bilateral inferior turbinate in humans with nasal septal deviation. PLoS One 9(6), e100219 (2014)
- H. Lim, S.H. Park, S.W. Kim, K.O. Cho, Therapeutic potential of human turbinatedderived mesenchymal stem cells in experimental acute ischemic stroke. Int. Neurourol. J. 22(Suppl 3), S131-S138 (2018)
- R.A. Pearson, Advances in repairing the degenerate retina by rod photoreceptor transplantation. Biotechnol. Adv. 32, 485-491 (2014)
- A. Rattner, J. Nathans, Macular degeneration: Recent advances and therapeutic opportunities. Nat. Rev. Neurosci. 7, 860-872 (2006)